gastric cancer

Showing NaN - NaN of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

Recruiting
  • Metastatic Solid Tumor
  • +6 more
  • Surufatinib and Tislelizumab _ Part 1
  • Surufatinib and Tislelizumab _ Part 2
  • Tucson, Arizona
  • +17 more
Apr 1, 2022

Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

Completed
  • Gastric Cancer
  • Los Angeles, California
  • +33 more
Feb 18, 2022

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022

Long-term, Non-interventional, Observational Study Following

Recruiting
  • Advanced Solid Tumor
  • +17 more
  • Allogeneic natural killer (NK) cell
  • San Diego, California
  • +3 more
Oct 15, 2021

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Gastric Cancer Trial in Worldwide (177Lu-3BP-227 (also called

Terminated
  • Pancreatic Ductal Adenocarcinoma
  • +7 more
  • 177Lu-3BP-227 (also called 177Lu-IPN01087)
  • Houston, Texas
  • +7 more
Jun 2, 2021

Helicobacter Pylori Genome Project (HpGP)

Terminated
  • Gastric Cancer
  • +2 more
    • Batesville, Arkansas
    • +93 more
    Dec 17, 2020

    Dose Escalation, Safety, Preliminary Efficacy Trial in Worldwide (LDE225, BKM120)

    Completed
    • Dose Escalation
    • +11 more
    • Los Angeles, California
    • +22 more
    Dec 16, 2020

    Stomach Cancer, Gastric Cancer Trial in Houston (drug, radiation, procedure)

    Completed
    • Stomach Cancer
    • Gastric Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 29, 2020

    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer Trial in United States (FOLFOX regimen,

    Completed
    • Adenocarcinoma of the Gastroesophageal Junction
    • +2 more
    • FOLFOX regimen
    • +5 more
    • Mobile, Alabama
    • +507 more
    Oct 25, 2019

    Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)

    Completed
    • Gastric Cancer
    • Adenocarcinoma
    • ramucirumab
    • +2 more
    • Bakersfield, California
    • +160 more
    Sep 10, 2019

    Gastric Cancer Trial in Worldwide (Ramucirumab (IMC-1211B) DP, Placebo, Paclitaxel)

    Completed
    • Gastric Cancer
    • Ramucirumab (IMC-1211B) DP
    • +2 more
    • Burbank, California
    • +166 more
    Sep 6, 2019

    Colorectal Cancer, Gastric Cancer, Hepatic Cancer Trial in Scottsdale, La Jolla, Houston (SM04755)

    Completed
    • Colorectal Cancer
    • +3 more
    • Scottsdale, Arizona
    • +2 more
    Sep 5, 2018

    Colorectal Cancer (CRC), Gastric Cancer Trial in United States (SC-007)

    Terminated
    • Colorectal Cancer (CRC)
    • Gastric Cancer
    • Los Angeles, California
    • +6 more
    Apr 25, 2018

    Gastric Cancer Trial in Worldwide (Taxane, trastuzumab emtansine)

    Terminated
    • Gastric Cancer
    • Bakersfield, California
    • +147 more
    May 5, 2017

    Motivational Counseling in Preventing Smoking Relapse After

    Completed
    • Bladder Cancer
    • +10 more
    • Smoking Prevention Usual Care
    • Counseling Intervention
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 21, 2016

    Head Neck Cancer, Liver Cancer, Breast Cancer Trial in United States (CUDC-101)

    Completed
    • Head and Neck Cancer
    • +4 more
    • Encinitas, California
    • +6 more
    Feb 1, 2016

    Esophageal Cancer, Gastric Cancer Trial in United States (drug, procedure, radiation)

    Completed
    • Esophageal Cancer
    • Gastric Cancer
    • Birmingham, Alabama
    • +68 more
    Nov 14, 2015

    Esophageal Cancer, Gastric Cancer Trial in Houston (rubitecan)

    Unknown status
    • Esophageal Cancer
    • Gastric Cancer
    • Houston, Texas
      University of Texas - MD Anderson Cancer Center
    Dec 3, 2013

    Esophageal Cancer, Gastric Cancer Trial in Canada, United States (erlotinib HCl)

    Completed
    • Esophageal Cancer
    • Gastric Cancer
    • erlotinib hydrochloride
    • Mobile, Alabama
    • +106 more
    Jun 21, 2013